Merck has characterized its cost-cutting initiative as more of a reallocation of resources to support other, higher-growth ...

Merck will reduce its workforce by approximately 6,000 employees in “some areas of our global workforce,” the New Jersey ...

Merck said it is embarking on a multi-year cost-savings plan, which includes cuts to its workforce and real-estate footprint, ...

Along with its financial results for the second quarter of 2025, Merck revealed a restructuring plan to save $3 billion by ...

Merck (MRK) is cutting $3 billion from its annual expenses as it prepares for generic competition to its blockbuster cancer drug, Keytruda.

The multi-year effort comes as Merck prepares to offset revenue losses from the upcoming patent expiration of its blockbuster cancer drug Keytruda.

Merck, a pharmaceutical company headquartered in Rahway, announced it will be undergoing layoffs after a disappointing second ...

Review the current Springer Nature AG & Co KGaA (SPG:XFRA) dividend yield and history to decide if SPG is the best investment for you.

Eli Lilly, Johnson & Johnson, and AbbVie are the largest companies in the healthcare sector.